Coverage
-
April 16, 2014
The Eighth Circuit on Tuesday refused to rehear en banc a ruling that cleared Eli Lilly & Co. of failing to warn that long-term users of the antipsychotic drug Zyprexa risk developing an involuntary movement disorder.
1 other articles on this case.
View all »